In overweight or obese adults without diabetes, semaglutide increased weight loss and GI disorders.
Where this comes from
- Record sourced from PubMed, PMID 34224258.
- Also identified by DOI 10.7326/ACPJ202107200-080.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Wilding JPH, Batterham RL, Calanna S, et al. <b>Once-weekly semaglutide in adults with overweight or obesity.</b> N Engl J Med. 2021;384:989. 33567185.
Medical subject headings
- Diabetes Mellitus
- Weight Loss